In Consulting Services

PharmaNet offers a comprehensive range of early- and late-phase consulting services on topics including: international regulatory affairs; scientific and medical affairs; quality; risk management; chemistry, manufacturing and controls; as well as biopharmaceutical investor issues.

Vaccines

PharmaNet Consulting personnel includes former senior-level staff in the FDA’s Office for Vaccine Research and Review (OVRR) and Office of Tissue, Cell / Gene Therapy (OTCGT). Available consulting services include assistance with: study design, regulatory strategy, Chemistry/Manufacturing Controls (CMC) issues, assessment of long-term risks, and interpreting actions and policies of worldwide regulatory agencies.

 

PharmaNet professionals available for consultation on this topic include:

 

William M. Egan, PhD

Vice President, PharmaNet Consulting

 

Joyce Lea Frey-Vasconcells, PhD

Executive Director, PharmaNet Consulting

 

PharmaNet Development Group, Inc.504 Carnegie Center, Princeton, NJ 08540Tel 609 951 6800Fax 609 514 0390